|
|
Kenya
|
H2022/CTD9937/21860
|
ENVUTEG
|
LAMIVUDINE USP , TENOFOVIR ALAFENAMIDE AND DOLUTEGRAVIR
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2020/CTD7079/13566
|
DOLUTEGRAVIR 50MG , LAMIVUDINE 300MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS
|
DOLUTEGRAVIR SODIUM,LAMIVUDINE USP TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2019/CTD7411/14564
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG TABLETS
|
EACH FILM COATED TABLET CONTAINS 52.6 MG OF DOLUTEGRAVIR SODIUM EQUIVALENT TO 50 MG OF DOLUTEGRAVIR, 300 MG OF LAMIVUDINE USP AND 300 MG OF TENOFOVIR DISOPROXIL FUMARATE (EQUIVALENT TO 245 MG OF TENOFOVIR DISOPROXIL).
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-25-179
|
Dolutegrvair, Lamivudine and Tenofovir Disoproxil Fumarate Tablets 50 mg/ 300 mg/ 300 mg
|
Dolutegravir Sodium 52.60 mg,Lamivudine USP 300 mg,Tenofovir Disoproxil Fumarate equivalent to Tenofovir Disoproxil 300 mg
|
Shanghai Desano Bio-Pharmaceutical Co., Ltd.
|
Registered/Compliant
|
Details →
|
|
|
Kenya
|
H2020/CTD7344/1654ER
|
TELATRI TABLETS
|
DOLUTEGRAVIR, LAMIVUDINE USP AND TENOFOVIR DISOPROXIL
|
SUN PHARMA EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2025/CTD12306/26376
|
ABACAVIR (AS SULFATE), DOLUTEGRAVIR (AS SODIUM) AND LAMIVUDINE 60 MG/ 5 MG/ 30 MG DISPERSIBLE TABLETS
|
ABACAVIR SULFATE USP DOLUTEGRAVIR SODIUM LAMIVUDINE USP
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 26 HM 0236
|
Abacavir, Dolutegravir and Lamivudine Dispersible Tablets 60mg / 5mg / 30mg
|
Abacavir Sulfate 60 mg,Acesulfame potassium 1.000 mg,Crospovidone (Type A) 4.000 mg,Crospovidone Type B (Polyplasdone XL-10) 17.500 mg,Dolutegravir Sodium 5 mg,Lamivudine USP 30 mg,Mannitol (Pearlitol 25C) 54.540 mg,Microcrystalline Cellulose (PH-101) 12.000 mg,Microcrystalline Cellulose PH-101 10.014 mg,Microcrystalline cellulose PH 101 24.085 mg,Opadry® II Complete film Coating System 85F520573 Yellow 7.000 mg,Povidone (Kollidon 30) 2.000 mg,Purified Water. 0.000 QS,Purified Water . 0.000 QS,Sodium Starch Glycolate（Type A） 11.000 mg,Sodium Stearyl Fumarate (PRUV) 1.200 mg,Sodium Stearyl Fumarate (PRUV) 2.700 mg,Strawberry 052311 AP0551 0.925 mg,Sucralose 2.500 mg,Sucralose 5.000 mg
|
Micro Labs Limited
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-1582
|
EFAVIRENZ 400 MG, LAMIVUDINE 300 MG AND TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS
|
Efavirenz USP, Lamivudine USP and Tenofovir Disoproxil fumarate
|
MACLEODS PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
Kenya
|
H2019/CTD7299/14303
|
EFAVIRENZ 400MG , LAMIVUDINE 300MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS
|
EFAVIRENZ USP,LAMIVUDINE USP, TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
Zambia
|
150/022
|
Tenofovir Disoproxil Fumarate and Lamivudine Tablets 300mg/300mg
|
Lamivudine USP 300 mg,Tenofovir Disoproxil Fumarate 300 mg
|
Hetero Labs Limited
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695A
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695B
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695C
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-2172
|
DOLUTEGRAVIR SODIUM 50MG, LAMIVUDINE USP 300 MG, TENOFOVIR DISOPROXIL FUMARATE 300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE USP, TENOFOVIR DISOPROXIL FUMARATE
|
CIPLA LTD
|
Registered
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-0261
|
DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE 50/300/300MG TABLETS
|
Dolutegravir sodium/Lamivudine USP/Tenofovir Disoproxil Fumarate 50mg/300mg/300mg
|
MACLEODS PHARMACEUTICALS LIMITED,
|
Registered
|
Details →
|
|
|
Kenya
|
H2021/CTD7784/14888
|
VIROPIL
|
LAMIVUDINE USP+TENOFOVIR DISOPROXIL FUMARATE+DOLUTEGRAVIR SODIUM
|
LAZOR PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
Tanzania
|
TAN 20 HM 0521
|
VIROPIL
|
Dolutegravir Sodium Equivalent to Dolutegravir 50 mg,Lamivudine USP 300 mg,Tenofovir Disoproxil Fumarate 300 mg Equivalent to Tenofovir Disoproxil 245 mg
|
-
|
Registered/Compliant
|
Details →
|
|
|
Kenya
|
H2013/CTD144/049
|
ABACAVIR SULFATE AND LAMIVUDINE TABLETS FOR ORAL SUSPENSION 60/30 MG
|
ABACAVIR SULFATE USP AND LAMIVUDINE USP
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-0839
|
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE TABLETS FOR SUSPENSION 30MG/50MG/60MG
|
Lamivudine USP 30 mg, Nevirapine USP 50 mg and Zidovudine USP 60 mg
|
CIPLA LIMITED,
|
Registered
|
Details →
|